EL
ELI LILLY + CO
LLY· Health Care· PharmaceuticalsS&P 500
Close · 16/09/2026
1,137.82
1D
+0.15%52-week range
712.05 – 1292.65
Volume
14,75,400.00
Price history
LLY
17/08/2026 to 16/09/2026
O 1,137.31 H 1,151.23 L 1,132.63
1W+1.21%
1M-3.83%
3M+1.36%
6M+22.30%
1Y+52.08%
3Y+91.05%
5Y+346.48%
MAX+381.41%
Fundamentals
as of 16/09/2026- Market cap
- $1.07T
- Shares out
- 941.36M
- P/E (trailing)
- 40.10
- P/E (forward)
- 23.62
- EPS (trailing)
- 28.37
- Dividend yield
- 0.59%
- Beta
- 0.50
- Profit margin
- 33.53%
- P/B
- 31.62
- Return on equity
- 78.84%
SEC financial statements
63 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- LLY
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
34 filers · 4 on watchlist · 55 buys · 65 sells · ?: 14 · R: 30 · D: 74 · I: 2
- 21/11/2025John BoozmanWSell+Eli Lilly and Company$1,001–$15,000
- 01/07/2026Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 02/01/2026Michael RulliBuyEli Lilly and Company Common Stock$1,001–$15,000
- 02/12/2025Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellEli Lilly and Company$15,001–$50,000
- 27/03/2026Alan ArmstrongSellEli Lilly and Company Common Stock$1,001–$15,000
- 10/07/2026Dan NewhouseSell+Eli Lilly and Company Common Stock$1,001–$15,000
- 10/06/2026Gilbert CisnerosBuyEli Lilly and Company Common Stock$50,001–$100,000